New Reference: Nivolumab plus cabozantinib in first-line treatment for advanced renal cell carcinoma
|New Reference: Nivolumab plus cabozantinib in first-line treatment for advanced renal cell carcinoma|
Lancet Oncol. 2022 Jul;23(7):888-898.
Motzer, Robert J et al. “Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial.”
Reviewed by Hasan Çağrı Yıldırım, MD on Jul 05, 2022
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.